Lantheus Holdings, Inc. (LNTH): A Bull Case Theory
We came across a bullish thesis on Lantheus Holdings, Inc. (LNTH) on Value Investing Subreddit Page by Small_Bodybuilder_12. In this article, we will summarize the bulls’ thesis on LNTH.
Lantheus Holdings Inc. (LNTH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 2,955,227 | $324,336,163 | +30% | 1.58% |
| 2. | Portolan Capital Management George Mccabe | 670,881 | $73,629,190 | +7% | 5.33% |
| 3. | Private Capital Management Gregg J. Powers | 517,418 | $56,786,626 | -4% | 6.08% |
| 4. | GMT Capital Thomas E. Claugus | 409,700 | $44,964,575 | -27% | 1.79% |
| 5. | Renaissance Technologies Jim Simons | 362,031 | $39,732,902 | +69% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.60 | 1,000 | Director | 16,211 | 2021-03-05 | Filing | |
| $18.02 | 1,000 | Director | 15,211 | 2021-02-26 | Filing | |
| $19.39 | 1,000 | Director | 14,211 | 2021-02-19 | Filing | |
| $20.03 | 1,000 | Director | 13,211 | 2021-02-12 | Filing | |
| $17.94 | 1,000 | Director | 12,211 | 2021-02-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.20 | 10,000 | Officer | 102,963 | 2024-11-15 | Filing | |
| $79.65 | 2,000 | Officer | 97,092 | 2024-11-14 | Filing | |
| $89.58 | 700 | Director | 443,436 | 2024-11-08 | Filing | |
| $88.78 | 2,900 | Director | 444,136 | 2024-11-08 | Filing | |
| $86.93 | 400 | Director | 447,036 | 2024-11-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,466,740 | $524,937,853 | 0.01% | |
| 2. | 4,520,000 | $506,511,200 | 0.09% | |
| 3. | 6,973,141 | $432,334,742 | 0% | |
| 4. | 3,947,571 | $244,752,795 | 0.14% | |
| 5. | 2,398,859 | $148,729,258 | 0% |
News See All
12 Most Profitable Pharmaceutical Stocks Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
Lantheus Holdings' (LNTH) Radiopharmaceutical Pipeline Fuels Growth Expectations
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q3 2024 Earnings Call Transcript
Operator: Good morning. Welcome to the Lantheus Third Quarter 2024 Conference Call. All lines have been placed on mute.
8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
8 High Growth High Margin Stocks to Invest In Now
When investor confidence is high, capital tends to flow into growth sectors, driving up stock prices and valuations.
10 Most Undervalued Quality Stocks To Buy According To Analysts
Despite global uncertainties, the US economy is viewed as stronger than its international counterparts.
Robust Quarterly Result Lifted Lantheus (LNTH) in Q2
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2024 Earnings Call Transcript
Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full Year [ph] 2024 Conference Call. This is your operator for today's call.
Is Lantheus Holdings Inc (NASDAQ:LNTH) the Best Jim Cramer Stock in 2024?
Jim Cramer in a latest program talked about the concept of “suitability” of stocks in investing, which emphasizes the importance of picking individual stocks based on your personal context, circumstances...
Billionaire Hedge Funds
